Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  European Journal of Pharmacology

• Publication date

  1989-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(89)90631-6PMID 2511032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit

  2004cited by this paper
• Inhibition of striatal acetylcholine release by serotonin and dopamine after the intracerebral administration of 6-hydroxydopamine to neonatal rats.

  1988cited by this paper
• Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.

  1988cited by this paper
• Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage

  1987cited by this paper
• Alpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production.

  1987cited by this paper
• Time Course of Adaptations in Dopamine Biosynthesis, Metabolism, and Release Following Nigrostriatal Lesions: Implications for Behavioral Recovery from Brain Injury

  1987cited by this paper
• Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery.

  1986cited by this paper
• Short-term effects of dopamine-depleting brain lesions on spontaneous activity of striatal neurons: relation to local dopamine concentration and behavior.

  1986cited by this paper
• Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis.

  1986cited by this paper
• Neural control of adenylate cyclase responsiveness in brown adipose tissue.

  1985cited by this paper
• Modulation of the endogenous acetylcholine release from rat striatal slices.

  1985cited by this paper
• High‐and Low‐Affinity States of Striatal D2 Receptors Are Not Affected by 6‐Hydroxydopamine or Chronic Haloperidol Treatment

  1984cited by this paper
• Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism.

  1984cited by this paper
• Frequency‐Dependent Release of Acetylcholine and Dopamine From Rabbit Striatum: Its Modulation by Dopaminergic Receptors

  1983cited by this paper
• Frequency-dependent effects of neuronal uptake inhibitors on the autoreceptor-mediated modulation of dopamine and acetylcholine release from the rabbit striatum.

  1983cited by this paper
• Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.

  1982cited by this paper
• Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum

  1982cited by this paper
• Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior.

  1981cited by this paper
• Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.

  1980cited by this paper
• Supersensitivity after intraventricular 6-hydroxydopamine: Relation to dopamine depletion

  1980cited by this paper
• A topographic measurement of brain pH.

  1980cited by this paper
• Simultaneous determination of catecholamines and unconjugated 3,4-dihydroxyphenylacetic acid in brain tissue by ion-pairing reverse-phase high-performance liquid chromatography with electrochemical detection.

  1980cited by this paper
• Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.

  1979cited by this paper
• In vitro acetylcholine release from rat caudate nucleus as a new model for testing drugs with dopamine-receptor activity

  1979cited by this paper
• Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: spontaneous recovery and pharmacological control.

  1979cited by this paper
• Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.

  1979cited by this paper
• Short-Term increase and long-term reversion of striatal cell activity after degeneration of the nigrostriatal dopamine system

  1978cited by this paper
• Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro

  1978cited by this paper
• Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.

  1977cited by this paper
• Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems.

  1977cited by this paper
• Presynaptic inhibition leading to disinhibition of acetylcholine release from interneurons of the caudate nucleus: Effects of dopamine, β-endorphin and d-Ala2-Pro5-enkephalinamide

  1977cited by this paper
• Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping.

  1976cited by this paper
• The neurochemistry of Parkinson's disease: effect of L-dopa therapy.

  1975cited by this paper
• In vivo inhibition of striatal acetycholine turnover by L-DOPA, apomophine and (plus)-amphetamine.

  1975cited by this paper
• Effects of dopaminergic drugs and acute medial forebrain bundle lesions on striatal acetylcholine levels.

  1975cited by this paper
• Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.

  1975cited by this paper
• Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.

  1975cited by this paper
• In vivo inhibition of striatal acetylcholine turnover by L-DOPA, apomorphine and (+)-amphetamine

  1975cited by this paper
• 6-Hydroxydopamine and striatal acetylcholine levels.

  1974cited by this paper
• Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum

  1974cited by this paper
• THE RELEASE OF LABELLED ACETYLCHOLINE AND CHOLINE FROM CEREBRAL CORTICAL SLICES STIMULATED ELECTRICALLY

  1974cited by this paper
• Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function.

  1974cited by this paper
• Influence of noncholinergic drugs on rat striatal acetylcholine levels.

  1974cited by this paper
• Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.

  1973cited by this paper
• Effects of 6-hydroxydopamine on acetylcholine and GABA metabolism in rat striatum.

  1973cited by this paper
• Recovery of Feeding and Drinking by Rats after Intraventricular 6-Hydroxydopamine or Lateral Hypothalamic Lesions

  1973cited by this paper
• Inhibition by hemicholinium-3 of (14C)acetylcholine synthesis and (3H)choline high-affinity uptake in rat striatal synaptosomes.

  1973cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• Deficits in Feeding Behavior after Intraventricular Injection of 6-Hydroxydopamine in Rats

  1972cited by this paper
• DEMONSTRATION OF ACETYLCHOLINE RELEASE BY MEASURING EFFLUX OF LABELLED CHOLINE FROM CEREBRAL CORTICAL SLICES

  1972cited by this paper
• Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.

  1971cited by this paper
• Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.

  1970cited by this paper
• EFFECTS OF 6‐HYDROXYDOPAMINE ON CATECHOLAMINE CONTAINING NEURONES IN THE RAT BRAIN

  1970cited by this paper
• A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

  1962cited by this paper

• Postsynaptic adaptations in direct pathway muscarinic M4-receptor signaling follow the temporal and regional pattern of dopaminergic degeneration

  2025influential citation
• Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA–induced dyskinetic behaviors

  2024cites this paper
• Rethinking the network determinants of motor disability in Parkinson’s disease

  2023cites this paper
• Distributed dopaminergic signaling in the basal ganglia and its relationship to motor disability in Parkinson's disease.

  2023cites this paper
• M4-mediated cholinergic transmission is reduced in parkinsonian mice and its restoration alleviates motor deficits and levodopa-induced dyskinesia

  2023cites this paper
• Cholinergic/glutamatergic co‐transmission in striatal cholinergic interneurons: new mechanisms regulating striatal computation

  2017cites this paper
• Electrophysiological properties of basal forebrain cholinergic neurons identified by genetic and optogenetic tagging

  2017cites this paper
• Cyproheptadine for the Prevention of Postoperative Delirium

  2016cites this paper
• Probing striatal microcircuitry to understand the functional role of cholinergic interneurons

  2015cites this paper
• Potential trade‐offs in treatment of premanifest Huntington's disease

  2015cites this paper
• 6-Hydroxydopamine Lesioning of Dopamine Neurons in Neonatal and Adult Rats Induces Age-Dependent Consequences

  2014cites this paper
• RESTORATION OF MOTOR AND NON-MOTOR FUNCTIONS BY NEUROTROPHIC FACTORS IN NONHUMAN PRIMATES WITH DOPAMINE DEPLETION

  2013cites this paper
• GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen

  2013cites this paper
• Chronic treatment with simvastatin affects cannabinoid receptor type 1 and muscarinic receptors type 2/4 in different brain regions among sham and 6-hydroxydopamine lesioned rats

  2013cites this paper
• Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.

  2012cites this paper
• TrkA Gene Ablation in Basal Forebrain Results in Dysfunction of the Cholinergic Circuitry

  2012cites this paper
• Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: A randomized controlled trial*

  2012cites this paper
• Elimination of the Vesicular Acetylcholine Transporter in the Striatum Reveals Regulation of Behaviour by Cholinergic-Glutamatergic Co-Transmission

  2011cites this paper
• Sıçan Striatal Dilimlerinden Bazal ve Uyarılma Koşullarında Asetilkolin ve Kolin Salıverilmesine Dopamin Reseptör Antagonistlerinin Etkisi

  2011cites this paper
• Dopamine D2‐receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive α4 nicotinic receptors via a cholinergic‐dependent mechanism

  2010cites this paper
• Cholinergic Interneuron and Parkinsonism

  2009cites this paper
• The Corticostriatal Pathway in Parkinson’s Disease

  2009cites this paper
• Degenerative and compensatory features in the striatum of MPTP-treated mice

  2008cites this paper
• Re-emergence of striatal cholinergic interneurons in movement disorders.

  2007cites this paper
• RGS9–2 Negatively Modulates l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease

  2007cites this paper
• Motor deficits and altered striatal gene expression in aphakia (ak) mice.

  2007cites this paper
• RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion

  2006cites this paper
• Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.

  2005cites this paper
• In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.

  2001cites this paper
• When it comes to communications between neurons, synapses are over-rated: insights from an animal model of parkinsonism.

  2000cites this paper
• Endogenous ACh enhances striatal NMDA‐responses via M1‐like muscarinic receptors and PKC activation

  1998cites this paper
• 6-Hydroxydopamine as a Tool for Studying Catecholamines in Adult Animals

  1998cites this paper
• The importance of age to the motoric effects of striatal dopamine depletion in an experimental model of Parkinson's Disease /

  1998cites this paper
• Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism.

  1997cites this paper
• The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease.

  1996cites this paper
• Dopaminergic inhibition of striatal GABA release after 6-hydroxydopamine.

  1996cites this paper
• Functional and molecular differentiation of the dopamine system induced by neonatal denervation.

  1996cites this paper
• Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression.

  1995cites this paper
• Dopaminergic modulation of striatal acetylcholine release in rats depleted of dopamine as neonates.

  1995cites this paper
• Chapter 15 Chemical transmission in the brain: homeostatic regulation and its functional implications

  1994cites this paper
• Chemical transmission in the brain: homeostatic regulation and its functional implications.

  1994cites this paper
• Effects of trihexyphenidyl and L-dopa on brain muscarinic cholinergic receptor binding measured by positron emission tomography

  1994cites this paper
• D1 and D2 dopamine receptors do not up-regulate in response to neonatal intrastriatal 6-hydroxydopamine lesions.

  1993cites this paper
• Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.

  1993cites this paper
• Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.

  1993cites this paper
• Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases.

  1993cites this paper
• Neurochemical Responses to 6‐Hydroxydopamine and L‐Dopa Therapy: Implications for Parkinson's Disease a

  1992cites this paper
• Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration.

  1992cites this paper
• Cholinergic/dopaminergic interaction in the rat striatum assessed from drug-induced repetitive oral movements.

  1992cites this paper
• Regulation of the activity of striatal cholinergic neurons by dopamine.

  1992cites this paper
• Non-synaptic interactions at presynaptic level.

  1991cites this paper
• Modulation of Gene Expression by Neuronal Lesions in the Rat Striatum

  1991cites this paper
• Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

  1991cites this paper
• Long‐Term Survival of Intrastriatal Dopaminergic Grafts: Modulation of Acetylcholine Release by Graft‐Derived Dopamine

  1991cites this paper
• Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.

  1991cites this paper
• Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.

  1991cites this paper
• Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.

  1991cites this paper
• Compensations after lesions of central dopaminergic neurons: some clinical and basic implications.

  1990cites this paper
• Effect of [1,3-di-n-butyl-7-(2-oxopropyl)-xanthine] (denbufylline), a low Km phosphodiesterase inhibitor, on striatal acetylcholine release in the rat: analysis using cerebral microdialysis.

  1990cites this paper
• Regulation of Striatal Acetylcholine Release by Dopamine after Nigrostriatal Bundle Injury

  1990cites this paper
• Neurotransmitter Actions and Interactions

  1990cites this paper
• Compensations in an animal model of Parkinsonism: implications for behavior under basal conditions and in response to stress

  1990cites this paper
• Modulating role of dopamine on anesthetic requirements

  1990cites this paper
• Partial damage to nigrostriatal bundle: compensatory changes and the action of L-dopa.

  1990cites this paper
• Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.

  1990cites this paper
• The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons.

  1990cites this paper
• Modulating role of dopamine on anesthetic requirements.

  1988cites this paper